Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/4885 |
Resumo: | Studies show the differences between the H1N1 virus and SARS-CoV-2, noting that in COVID-19 positive patients there is a non-productive cough, gastrointestinal symptoms and fatigue, while in the H1N1 virus infection, productive cough and fever occur. This study aims to compare the similarities and differences between infections by Influenza A (H1N1) and SARS-CoV-2 (COVID-19) associating these diseases with the Acute Respiratory Discomfort Syndrome (ARDS). It is a qualitative bibliographic review that is based on the production based on studies already published. There are some similarities between the symptoms and transmission of H1N1 and Coronavirus, and as a result, it is necessary to differentiate them and discuss the epidemiological impact caused. The transmission of viruses generally occurs through contact with droplets of saliva or mucus from infected patients, mainly through sneezing and coughing. SARS-CoV-2 has a higher transmission rate compared to the H1N1 virus. Asymptomatic cases can occur in COVID-19 infection, in H1N1 this does not happen. The H1N1 virus has treatments, and vaccine available, while in COVID-19 there is still no fully effective treatment and vaccine development is still underway. Although there are similarities in the two infections, COVID-19 has a higher lethality rate and a greater spread of the infection. |
id |
UNIFEI_cb30e792786f5da39dc110d61cb1535a |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/4885 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndromeInfluenza (H1N1), sars-cov-2 y asociación con síndrome agudo de discosteo respiratorioInfluenza (H1N1), sars-cov-2 e associação com a síndrome do desconforto respiratório agudoEpidemiaGripe ACovid-19Insuficiencia RespiratoriaEpidemiaInfluenza ACovid-19Insuficiência Respiratória.EpidemicInfluenza ACovid-19Respiratory Failure.Studies show the differences between the H1N1 virus and SARS-CoV-2, noting that in COVID-19 positive patients there is a non-productive cough, gastrointestinal symptoms and fatigue, while in the H1N1 virus infection, productive cough and fever occur. This study aims to compare the similarities and differences between infections by Influenza A (H1N1) and SARS-CoV-2 (COVID-19) associating these diseases with the Acute Respiratory Discomfort Syndrome (ARDS). It is a qualitative bibliographic review that is based on the production based on studies already published. There are some similarities between the symptoms and transmission of H1N1 and Coronavirus, and as a result, it is necessary to differentiate them and discuss the epidemiological impact caused. The transmission of viruses generally occurs through contact with droplets of saliva or mucus from infected patients, mainly through sneezing and coughing. SARS-CoV-2 has a higher transmission rate compared to the H1N1 virus. Asymptomatic cases can occur in COVID-19 infection, in H1N1 this does not happen. The H1N1 virus has treatments, and vaccine available, while in COVID-19 there is still no fully effective treatment and vaccine development is still underway. Although there are similarities in the two infections, COVID-19 has a higher lethality rate and a greater spread of the infection.Los estudios muestran las diferencias entre el virus H1N1 y el SARS-CoV-2, señalando que en los pacientes con COVID-19 positivo hay tos no productiva, síntomas gastrointestinales y fatiga, mientras que en la infección por el virus H1N1, se producen tos productiva y fiebre. Este estudio tiene como objetivo comparar las similitudes y diferencias entre las infecciones por Influenza A (H1N1) y SARS-CoV-2 (COVID-19) que asocian estas enfermedades con el Síndrome de incomodidad respiratoria aguda (SDRA). Es una revisión bibliográfica cualitativa que se basa en la producción basada en estudios ya publicados. Existen algunas similitudes entre los síntomas y la transmisión de H1N1 y Coronavirus, y como resultado, es necesario diferenciarlos y discutir el impacto epidemiológico causado. La transmisión de virus generalmente ocurre a través del contacto con gotas de saliva o moco de pacientes infectados, principalmente a través de estornudos y tos. El SARS-CoV-2 tiene una tasa de transmisión más alta en comparación con el virus H1N1. Pueden ocurrir casos asintomáticos en la infección por COVID-19, en H1N1 esto no sucede. El virus H1N1 tiene tratamientos y vacunas disponibles, mientras que en COVID-19 todavía no existe un tratamiento totalmente efectivo y el desarrollo de la vacuna aún está en marcha. Aunque existen similitudes en las dos infecciones, COVID-19 tiene una tasa de mortalidad más alta y una mayor propagación de la infección.Estudos mostram as diferenças entre o vírus H1N1 e o SARS-CoV-2, observando que em pacientes COVID-19 positivos há uma presença de tosse não produtiva, sintomas gastrointestinais e fadiga, enquanto na infecção pelo vírus H1N1, ocorre tosse produtiva e febre. Este estudo tem por finalidade, comparar as semelhanças e diferenças entre as infecções pela Influenza A (H1N1) e SARS-CoV-2 (COVID-19) associando estas doenças com a Síndrome do Desconforto Respiratório Agudo (SDRA). Trata-se de uma revisão bibliográfica de caráter qualitativo que se baseia na produção a partir de estudos já publicados. Existem algumas semelhanças entre os sintomas e transmissão da H1N1 e do Coronavírus, e em consequência disso é preciso diferencia-los e discutir sobre o impacto epidemiológico causado. A transmissão dos vírus, em geral ocorre através do contato com gotículas de saliva ou muco de pacientes infectados, principalmente através de espirros e tosse. O SARS-CoV-2 possui uma maior taxa de transmissão em relação ao vírus da H1N1. Na infecção por COVID-19 pode ocorrer casos assintomáticos, na H1N1 isso não acontece. O vírus da H1N1 apresenta tratamentos, e vacina disponível, enquanto na COVID-19 ainda não existe um tratamento totalmente eficaz e o desenvolvimento de vacinas ainda está em execução. Embora existam semelhanças nas duas infecções, a COVID-19 possui uma taxa de letalidade mais alta e uma expansão maior da infecção.Research, Society and Development2020-06-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/488510.33448/rsd-v9i8.4885Research, Society and Development; Vol. 9 No. 8; e58984885Research, Society and Development; Vol. 9 Núm. 8; e58984885Research, Society and Development; v. 9 n. 8; e589848852525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/4885/4470Copyright (c) 2020 Lennara Pereira Motainfo:eu-repo/semantics/openAccessMota, Lennara PereiraAlmeida, Malena GonçalvesSantos, Bárbara Sandra Pinheiro dosSousa, Daiane Carvalho deAnjos, Luana Ribeiro dosMoreira, Geovane Bruno OliveiraBarros, Layara FernandesCastro, Vandelma Lopes deRodrigues, Francielly de SousaSilva, Danyele Holanda daAleluia, Raquel Gomes GonzalezReis, Mayara Rafaela dosVale, Mônica Maria Santos doVenturoso, Inara Correia da Costa MoraisRaiol, Sanderson Rodrigo do NascimentoSilva, Maurício Jammes de Sousa2020-08-20T18:00:17Zoai:ojs.pkp.sfu.ca:article/4885Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:28:35.667471Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome Influenza (H1N1), sars-cov-2 y asociación con síndrome agudo de discosteo respiratorio Influenza (H1N1), sars-cov-2 e associação com a síndrome do desconforto respiratório agudo |
title |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome |
spellingShingle |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome Mota, Lennara Pereira Epidemia Gripe A Covid-19 Insuficiencia Respiratoria Epidemia Influenza A Covid-19 Insuficiência Respiratória. Epidemic Influenza A Covid-19 Respiratory Failure. |
title_short |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome |
title_full |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome |
title_fullStr |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome |
title_full_unstemmed |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome |
title_sort |
Influenza (H1N1), sars-cov-2 and association with acute respiratory discomfort syndrome |
author |
Mota, Lennara Pereira |
author_facet |
Mota, Lennara Pereira Almeida, Malena Gonçalves Santos, Bárbara Sandra Pinheiro dos Sousa, Daiane Carvalho de Anjos, Luana Ribeiro dos Moreira, Geovane Bruno Oliveira Barros, Layara Fernandes Castro, Vandelma Lopes de Rodrigues, Francielly de Sousa Silva, Danyele Holanda da Aleluia, Raquel Gomes Gonzalez Reis, Mayara Rafaela dos Vale, Mônica Maria Santos do Venturoso, Inara Correia da Costa Morais Raiol, Sanderson Rodrigo do Nascimento Silva, Maurício Jammes de Sousa |
author_role |
author |
author2 |
Almeida, Malena Gonçalves Santos, Bárbara Sandra Pinheiro dos Sousa, Daiane Carvalho de Anjos, Luana Ribeiro dos Moreira, Geovane Bruno Oliveira Barros, Layara Fernandes Castro, Vandelma Lopes de Rodrigues, Francielly de Sousa Silva, Danyele Holanda da Aleluia, Raquel Gomes Gonzalez Reis, Mayara Rafaela dos Vale, Mônica Maria Santos do Venturoso, Inara Correia da Costa Morais Raiol, Sanderson Rodrigo do Nascimento Silva, Maurício Jammes de Sousa |
author2_role |
author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Mota, Lennara Pereira Almeida, Malena Gonçalves Santos, Bárbara Sandra Pinheiro dos Sousa, Daiane Carvalho de Anjos, Luana Ribeiro dos Moreira, Geovane Bruno Oliveira Barros, Layara Fernandes Castro, Vandelma Lopes de Rodrigues, Francielly de Sousa Silva, Danyele Holanda da Aleluia, Raquel Gomes Gonzalez Reis, Mayara Rafaela dos Vale, Mônica Maria Santos do Venturoso, Inara Correia da Costa Morais Raiol, Sanderson Rodrigo do Nascimento Silva, Maurício Jammes de Sousa |
dc.subject.por.fl_str_mv |
Epidemia Gripe A Covid-19 Insuficiencia Respiratoria Epidemia Influenza A Covid-19 Insuficiência Respiratória. Epidemic Influenza A Covid-19 Respiratory Failure. |
topic |
Epidemia Gripe A Covid-19 Insuficiencia Respiratoria Epidemia Influenza A Covid-19 Insuficiência Respiratória. Epidemic Influenza A Covid-19 Respiratory Failure. |
description |
Studies show the differences between the H1N1 virus and SARS-CoV-2, noting that in COVID-19 positive patients there is a non-productive cough, gastrointestinal symptoms and fatigue, while in the H1N1 virus infection, productive cough and fever occur. This study aims to compare the similarities and differences between infections by Influenza A (H1N1) and SARS-CoV-2 (COVID-19) associating these diseases with the Acute Respiratory Discomfort Syndrome (ARDS). It is a qualitative bibliographic review that is based on the production based on studies already published. There are some similarities between the symptoms and transmission of H1N1 and Coronavirus, and as a result, it is necessary to differentiate them and discuss the epidemiological impact caused. The transmission of viruses generally occurs through contact with droplets of saliva or mucus from infected patients, mainly through sneezing and coughing. SARS-CoV-2 has a higher transmission rate compared to the H1N1 virus. Asymptomatic cases can occur in COVID-19 infection, in H1N1 this does not happen. The H1N1 virus has treatments, and vaccine available, while in COVID-19 there is still no fully effective treatment and vaccine development is still underway. Although there are similarities in the two infections, COVID-19 has a higher lethality rate and a greater spread of the infection. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-06-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/4885 10.33448/rsd-v9i8.4885 |
url |
https://rsdjournal.org/index.php/rsd/article/view/4885 |
identifier_str_mv |
10.33448/rsd-v9i8.4885 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/4885/4470 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Lennara Pereira Mota info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Lennara Pereira Mota |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 8; e58984885 Research, Society and Development; Vol. 9 Núm. 8; e58984885 Research, Society and Development; v. 9 n. 8; e58984885 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052641394556928 |